RESUMO
INTRODUÇÃO: O Implante transcateter da valva pulmonar (ITVP) é terapia consagrada para o reestabelecimento da via de saída do ventrículo direito (VD) em pacientes com disfunção pulmonar grave. Apesar de promover melhora do VD, pouco se sabe sobre o seu impacto na qualidade de vida (QV). MÉTODOS: Estudo prospectivo e multicêntrico com pacientes submetidos ao ITVP, com enfoque no impacto clínico e na qualidade de vida. Pacientes com disfunção pulmonar grave e submetidos ao ITVP foram incluídos. Dados clínicos, ecocardiográficos (ECO), de teste cardiopulmonar (TCP) e ressonância magnética (RNM) previamente e 1 ano após o ITVP foram comparados (média e desvio-padrão). Da mesma forma, foi avaliada a qualidade de vida através do questionário SF-36 para os maiores de 18 anos e SF-10 para os menores. RESULTADOS: De 17/12/2013 a 31/12/2017 foram incluídos 19 pacientes (11 masculinos). No procedimento tinham média de 21,0±7,1 anos e 56,2±15,7 Kg. O número de cirurgias prévias foi de 2 (1-4) e o tempo desde a última foi 10,6±5,6 anos. Dez pacientes apresentavam estenose pulmonar (53%), 4 insuficiências (21%) e 5 lesões mista (26%). Foi observado sucesso imediato, com queda do gradiente sistólico ao cate de 38,8±22,0 para 9,9±6,8 mmHg e relação das pressões do VD/Aorta de 0,70±0,21 para 0,37±0,07 mmHg (ambos p 0,001). Após 1 ano de seguimento, houve melhora dos índices: Classe funcional de 2 (1-3) para 1 (1-2) (p < 0,001), frequência cardíaca máxima ao TCP de 81,0±7,9 para 85,9±11,4 bpm (p 0,006), volumes diastólico e sistólico finais de VD (VDFVD e VSFVD) à RNM de 109,1±33,3 e 60,8±29,0 ml/m2 para 92,5±29,2 e 47,9±19,9 ml/m2 (p <0,0001 e p 0,004), respectivamente. Além disto, aumento dos VDFVE e VSFVE de 80,0±19,6 e 32,1±10,6 ml/m2 para 87,9±16,2 e 37,7±10,8 ml/m2 (p 0,049 e p 0,035). A análise da QV mostrou melhora somente nos pacientes maiores de 18 anos, com aumento da percepção de saúde física (PCS) de 45,7±8,0 para 52,1±6,3 (p 0,006) e saúde mental (MCS) de 46,1±11,2 para 55,1±8,4 (p 0,008). Neste período, não houve óbitos. Um dos pacientes apresentou endocardite bacteriana 9 meses após o implante e necessitou cirurgia cardíaca para troca valvar, com sucesso, sem complicações. CONCLUSÃO: O ITVP mostrou-se factível, seguro eficaz na primeira experiência brasileira. Após 1 ano de seguimento, houve inquestionável melhora clínica e na qualidade de vida - esta última, somente nos pacientes maiores de idade, provavelmente em virtude do baixo número de incluídos. (AU)
Assuntos
Humanos , Pacientes , Qualidade de Vida , Substituição da Valva Aórtica TranscateterRESUMO
OBJECTIVES: The aim of this study was to test the hypothesis that experimental maternal intake of green tea in late pregnancy causes fetal ductus arteriosus constriction, probably because of prostaglandin inhibition. METHODS AND RESULTS: Twelve fetal lambs (pregnancy > 120 days) were assessed before and after maternal administration of green tea (n = 8) or water (n = 4; controls) as the only source of liquid. After 1 week, echocardiography showed signs of constriction of the ductus arteriosus in all fetuses from mothers ingesting green tea, with increase in mean systolic velocity(from 0.70 ± 0.19 m/s to 0.92 ± 0.15 m/s, 31.4%, p = 0.001) and mean diastolic velocity (0.19 ± 0.05 m/s to 0.31 ± 0.01 m/s, 63.1%, p < 0.001), decrease of pulsatility index (2.2 ± 0.4 to 1.8 ± 0.3, 22.2%, p = 0.003) and increase of mean right ventricular/left ventricular diameter ratio (0.89 ± 0.14 to 1.43 ± 0.23, 60.6%, p < 0.001). In the four control fetuses, there were no significant changes. All lambs exposed to green tea also showed at autopsy dilated and hypertrophic right ventricles, which was not present in control fetuses. Histological analysis showed a significantly larger mean thickness of the medial avascular zone of the ductus arteriosus in fetuses exposed to green tea than in controls (747.6 ± 214.6 µm vs 255.3 ± 97.9 µm, p < 0.001). CONCLUSIONS: This study in fetal lambs shows a cause and effect relationship between experimental maternal exposure of green tea and fetal ductus arteriosus constriction in late pregnancy.
Assuntos
Canal Arterial/embriologia , Idade Gestacional , Ovinos/embriologia , Chá/efeitos adversos , Animais , Constrição Patológica/diagnóstico por imagem , Constrição Patológica/patologia , Constrição Patológica/veterinária , Canal Arterial/diagnóstico por imagem , Canal Arterial/patologia , Feminino , Modelos Animais , Gravidez , Antagonistas de Prostaglandina , Ultrassonografia Pré-Natal/veterináriaRESUMO
OBJECTIVES: The aim of this article is to report a 16-year experience with percutaneous balloon aortic valvuloplasty (BAVP) in newborns and young infants up to 3 months of age in a tertiary care cardiac reference center in a developing country and to determine its value in postponing open heart surgery. BACKGROUND: Congenital aortic stenosis (AS) is a potentially life threatening disorder. BAVP and surgical procedures have similar short and medium-term efficacy. METHODS: Thirty-one consecutive newborns and young infants with critical AS underwent BAVP in our department from 1991 to 2007. Mean patient age at time of the procedure was 22 days (range 2-92 days) and mean weight was 3,310 g (1,840-4,400 g). RESULTS: There was a significant reduction in mean Doppler-derived peak gradient across the aortic valve immediately after the procedure (75.1 ± 22 versus 32.2 ± 13.02, P < 0.001), and this finding was maintained throughout follow-up. Since 2003, when the carotid approach became routine practice, no major vascular complications were observed. Mean time of follow-up was 81 months (5 days-196 months) with only two deaths (7.4%). Only 24% patients required surgical reintervention on the aortic valve during follow-up. Survival free from aortic valve surgery was 80% at 24 months, 66% at 63 months, and 50% at 80 months. CONCLUSION: Percutaneous intervention for relief of critical aortic stenosis in newborns in a tertiary center of a developing country is safe and has excellent short and long-term results comparable to other centers throughout the world.
Assuntos
Estenose da Valva Aórtica/terapia , Artérias Carótidas , Cateterismo/métodos , Artéria Femoral , Estenose da Valva Aórtica/congênito , Estenose da Valva Aórtica/diagnóstico por imagem , Estenose da Valva Aórtica/mortalidade , Estenose da Valva Aórtica/fisiopatologia , Brasil , Procedimentos Cirúrgicos Cardíacos , Cateterismo/efeitos adversos , Cateterismo/mortalidade , Países em Desenvolvimento , Intervalo Livre de Doença , Ecocardiografia Doppler , Feminino , Hemodinâmica , Mortalidade Hospitalar , Humanos , Lactente , Recém-Nascido , Estimativa de Kaplan-Meier , Masculino , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Taxa de Sobrevida , Fatores de Tempo , Resultado do TratamentoRESUMO
Introdução: O forame oval (FO) tem extrema importância na circulação fetal, pois conduz o sangue oxigenado proveniente da placenta diretamente ao átrio esquerdo. Frequentemente fetos de mães diabéticas(FMD) apresentam hipertrofia miocárdica(HM), com alterações na função diastólica ventricular esquerda, podendo acarretar modificações do fluxo pelo FO, com reflexo no índice de pulsatilidade. Objetivo: Testar a hipótese de que o fluxo pelo FO apresenta índice de pulsatilidade maior em FMD com HM do que em fetos sem HM de mães com ou sem diabetes. Métodos: Trata-se de um estudo transversal controlado comparando FMD com HM com FMD sem hipertrofia e fetos controles normais. Pacientes: 16 FMD com HM(grupo I), 36 FMD sem HM(grupo II) e 39 fetos controles normais(grupo III), A ecocardiografia fetal com Doppler foi realizada para obter o índice de pulsatilidade do forame oval(IPFO), através da razão velocidade sistólica-velocidade pré-sistólica/velocidade média. Foram utilizados ANOVA e teste das diferenças mínimas significativas, com alfa crítico de 0,05. Resultados: O IPFO médio foi de 4,07 mais ou menos 1,33 no grupo I, 2,28 mais ou menos 0,58 no grupo II e 2,78 mais ou menos 0,55 no grupo III. Houve diferença estatisticamente significante entre os grupos (p menor 0,001); os valores de IPFO do grupo I foram significativamente maiores dos que o do grupo II e III (p menor 0,001). Os valores do IPFO do grupo II não foram significativamente diferentes em relação ao grupo III (p igual 0,604). Conclusão: Fetos de mães diabéticas com hipertrofia miocárdica têm o índice de pulsatilidade do fluxo do forame oval maior do que os fetos sem hipertrofia miocárdica e fetos controles normais. Sugere-se que sua diferença ocorra por uma complacência diminuída do ventriculo esquerdo secundária à hipertrofia do septo interventricular.
Assuntos
Humanos , Feto/embriologia , Septos Cardíacos/crescimento & desenvolvimento , Diabetes Mellitus/diagnósticoRESUMO
OBJECTIVE: To describe the relative incidence, presentation, and evolvement of fetuses with early ductus constriction. METHODS: Twenty fetal echocardiograms indicating ductus constriction were reviewed in a population of 7000 pregnants. RESULTS: The cases were divided into group A (related to maternal use of cyclooxygenase inhibitors [n=7] and group B (idiopathics [n=13]). Mean gestational age was 32.5 +/- 3.1 (27-38) weeks and maternal age was 28.2 +/- 8.5 (17-42) years. Mean systolic velocity in the ductus was 2.22 +/- 0.34 (1.66-2.81) m/s, diastolic velocity 0.79 +/- 0.28 (0.45-1.5) m/s, and pulsatility index 1.33 +/- 0.36 (0.52-1.83). Two cases of ductal occlusion were noted. In 65% of the cases, an increase occurred in the right cavities; in 90% of the cases, tricuspid or pulmonary regurgitation, or both, occurred, with functional pulmonary atresia in 1 case. Diastolic velocity was greater in group A (1.13 +/- 0.33) than in group B (0.68 +/- 0.15) (P=0.008). The other data were similar in the 2 groups. The evolvement was not favorable in 4 patients from group B, including 1 death and 2 cases of persistent pulmonary hypertension. CONCLUSION: The high incidence of idiopathic constriction of the ductus arteriosus suggests that its diagnosis is underestimated and that many cases of persistence of fetal circulation in newborns may be related to constriction of the ductus arteriosus not diagnosed during intrauterine life. Group B had a lower severity but a risk of an unfavorable evolvement, suggesting a distinct alteration.
Assuntos
Canal Arterial/diagnóstico por imagem , Adolescente , Adulto , Anti-Inflamatórios não Esteroides/efeitos adversos , Velocidade do Fluxo Sanguíneo/efeitos dos fármacos , Estudos de Coortes , Constrição Patológica/induzido quimicamente , Constrição Patológica/diagnóstico por imagem , Inibidores de Ciclo-Oxigenase/efeitos adversos , Canal Arterial/efeitos dos fármacos , Canal Arterial/fisiopatologia , Ecocardiografia Doppler em Cores , Feminino , Idade Gestacional , Humanos , Incidência , Recém-Nascido , Gravidez , Resultado da Gravidez , Índice de Gravidade de Doença , Estatísticas não ParamétricasRESUMO
OBJECTIVE: To verify the hypothesis that the pulmonary vein pulsatility index is higher in fetuses of diabetic mothers than it is in normal fetuses of nondiabetic mothers. METHODS: Twenty-four fetuses of mothers with either gestational or previous diabetes (cases), and 25 normal fetuses of mothers without systemic disease (control) were examined. Fetuses were examined through prenatal Doppler and color flow mapping. The pulmonary vein pulsatility index was obtained by placing the pulsed Doppler sample volume over the right superior pulmonary vein and applying the formula (systolic velocity - presystolic velocity)/mean velocity. RESULTS: The mean gestational age of the study fetuses was 30.3±2.7 weeks, and gestational age of the controls was 29±3.3 weeks, with no significant difference in gestational age between groups (p=0.14). Fetuses of diabetic mothers had a mean pulmonary vein pulsatility index of 1.6±1, and those of the control group had an index of 0.86±0.27. CONCLUSION: Fetuses of diabetic mothers had pulmonary vein pulsatility indexes (parameter easily obtained through Doppler echocardiography that may be related to fetal diastolic function) higher than those in fetuses of mothers with normal glycemia
Assuntos
Humanos , Feminino , Gravidez , Diabetes Mellitus , Ecocardiografia Doppler , Doenças Fetais , Circulação Pulmonar , Veias Pulmonares , Fluxo Pulsátil , Ultrassonografia Pré-Natal , Velocidade do Fluxo Sanguíneo , Estudos de Casos e Controles , Diástole , Feto , Idade Gestacional , Pulmão , Veias Pulmonares , SístoleRESUMO
OBJECTIVE: To describe the relative incidence, presentation, and evolvement of fetuses with early ductus constriction. METHODS: Twenty fetal echocardiograms indicating ductus constriction were reviewed in a population of 7000 pregnants. RESULTS: The cases were divided into group A (related to maternal use of cyclooxygenase inhibitors [n=7] and group B (idiopathics [n=13]). Mean gestational age was 32.5±3.1 (27-38) weeks and maternal age was 28.2±8.5 (17-42) years. Mean systolic velocity in the ductus was 2.22±0.34 (1.66-2.81) m/s, diastolic velocity 0.79±0.28 (0.45-1.5) m/s, and pulsatility index 1.33±0.36 (0.52-1.83). Two cases of ductal occlusion were noted. In 65 percent of the cases, an increase occurred in the right cavities; in 90 percent of the cases, tricuspid or pulmonary regurgitation, or both, occurred, with functional pulmonary atresia in 1 case. Diastolic velocity was greater in group A (1.13±0.33) than in group B (0.68±0.15) (P=0.008). The other data were similar in the 2 groups. The evolvement was not favorable in 4 patients from group B, including 1 death and 2 cases of persistent pulmonary hypertension. CONCLUSION: The high incidence of idiopathic constriction of the ductus arteriosus suggests that its diagnosis is underestimated and that many cases of persistence of fetal circulation in newborns may be related to constriction of the ductus arteriosus not diagnosed during intrauterine life. Group B had a lower severity but a risk of an unfavorable evolvement, suggesting a distinct alteration
Assuntos
Humanos , Feminino , Gravidez , Constrição Patológica , Canal Arterial , Anti-Inflamatórios não Esteroides , Velocidade do Fluxo Sanguíneo , Estudos de Coortes , Constrição Patológica , Inibidores de Ciclo-Oxigenase , Idade Gestacional , Incidência , Resultado da GravidezRESUMO
OBJECTIVE: To verify the hypothesis that the pulmonary vein pulsatility index is higher in fetuses of diabetic mothers than it is in normal fetuses of nondiabetic mothers. METHODS: Twenty-four fetuses of mothers with either gestational or previous diabetes (cases), and 25 normal fetuses of mothers without systemic disease (control) were examined. Fetuses were examined through prenatal Doppler and color flow mapping. The pulmonary vein pulsatility index was obtained by placing the pulsed Doppler sample volume over the right superior pulmonary vein and applying the formula (systolic velocity - presystolic velocity)/mean velocity. RESULTS: The mean gestational age of the study fetuses was 30.3 2.7 weeks, and gestational age of the controls was 29 3.3 weeks, with no significant difference in gestational age between groups (p=0.14). Fetuses of diabetic mothers had a mean pulmonary vein pulsatility index of 1.6 1, and those of the control group had an index of 0.86 0.27. CONCLUSION: Fetuses of diabetic mothers had pulmonary vein pulsatility indexes (parameter easily obtained through Doppler echocardiography that may be related to fetal diastolic function) higher than those in fetuses of mothers with normal glycemia.